[{"id":"68078b0d-d5ab-4473-9bbc-13859ce40855","acronym":"","url":"https://clinicaltrials.gov/study/NCT06037317","created_at":"2023-09-14T14:12:50.055Z","updated_at":"2024-07-02T16:35:21.175Z","phase":"Phase 1","brief_title":"A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors","source_id_and_acronym":"NCT06037317","lead_sponsor":"Shouyao Holdings (Beijing) Co. LTD","biomarkers":" LTK","pipe":"","alterations":" ","tags":["LTK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ficonalkib (SY-3505)"],"overall_status":"Recruiting","enrollment":" Enrollment 38","initiation":"Initiation: 05/30/2024","start_date":" 05/30/2024","primary_txt":" Primary completion: 12/30/2025","primary_completion_date":" 12/30/2025","study_txt":" Completion: 05/30/2026","study_completion_date":" 05/30/2026","last_update_posted":"2024-02-02"}]